Literature DB >> 12524492

[Epidemiologic of primary bronchial carcinoma management in the general French hospital centers].

F Blanchon1, M Grivaux, T Collon, M Zureik, H Barbieux, M Bénichou-Flurin, J L Breton, D Coëtmeur, B Delclaux, B Asselain, J Piquet.   

Abstract

INTRODUCTION: The College of General Hospital Respiratory Physicians have conducted a study aimed at a better understanding of the details and modalities of management of patients suffering from bronchial carcinoma in general hospitals in France.
MATERIALS AND METHODS: A prospective epidemiological study was carried out on all the new cases of histologically proven bronchial carcinoma seen in general hospitals in the year 2000. The data were collected by a standardised questionnaire.
RESULTS: 137 centres of investigation identified 5 667 patients, mean age 64.3 years, of whom 16% were women. 7.2% of patients were non smokers (with an incidence of 32.3% non-smokers among the women) and 40.3% were ex-smokers. Histologically 16.9% were small cell carcinomas, 40% squamous carcinomas (43.1% among the men, 23.4% among the women, p<0.0001), 30.1% adenocarcinomas (27.2% among the men, 45.3% among the women, p<0.0001). 77.1% of non small cell carcinomas were stages III and IV, and 66.8% of small cell carcinomas were disseminated, with no difference between the sexes.
CONCLUSION: Respiratory physicians in general hospitals manage more than a quarter of the cases of bronchial carcinoma seen annually in France. The number of women affected is high with a significant percentage of non-smokers and adenocarcinomas.

Entities:  

Mesh:

Year:  2002        PMID: 12524492

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  13 in total

Review 1.  Tumour molecular profiling for deciding therapy-the French initiative.

Authors:  Frédérique Nowak; Jean-Charles Soria; Fabien Calvo
Journal:  Nat Rev Clin Oncol       Date:  2012-07-10       Impact factor: 66.675

Review 2.  Optimal pharmacotherapeutic strategies for elderly patients with advanced non-small cell lung cancer.

Authors:  Elisabeth Quoix
Journal:  Drugs Aging       Date:  2011-11-01       Impact factor: 3.923

3.  Therapeutic options in older patients with metastatic non-small cell lung cancer.

Authors:  Elisabeth Quoix
Journal:  Ther Adv Med Oncol       Date:  2012-09       Impact factor: 8.168

4.  New insights into stage and prognosis in small cell lung cancer: an analysis of 968 cases.

Authors:  Charles Dayen; Didier Debieuvre; Olivier Molinier; Olivier Raffy; Fabrice Paganin; Jérôme Virally; Sébastien Larive; Béatrice Desurmont-Salasc; Marielle Perrichon; Francis Martin; Michel Grivaux
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

5.  Incidence of solitary pulmonary nodules in Northeastern France: a population-based study in five regions.

Authors:  Émilie Marrer; Damien Jolly; Patrick Arveux; Catherine Lejeune; Marie-Christine Woronoff-Lemsi; Jérémie Jégu; Francis Guillemin; Michel Velten
Journal:  BMC Cancer       Date:  2017-01-11       Impact factor: 4.430

6.  Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial.

Authors:  Akira Nakao; Osamu Hiranuma; Junji Uchino; Chikara Sakaguchi; Toshiyuki Kita; Noriya Hiraoka; Tamotsu Ishizuka; Yutaka Kubota; Masayuki Kawasaki; Yasuhiro Goto; Hisao Imai; Noboru Hattori; Keita Nakatomi; Hidetaka Uramoto; Kiyoaki Uryu; Minoru Fukuda; Yasuki Uchida; Toshihide Yokoyama; Masaya Akai; Tadashi Mio; Seiji Nagashima; Yusuke Chihara; Nobuyo Tamiya; Yoshiko Kaneko; Takako Mouri; Tadaaki Yamada; Kenichi Yoshimura; Masaki Fujita; Koichi Takayama
Journal:  Oncologist       Date:  2019-01-16

7.  [Diagnostic delay in bronchopulmonary cancers at the USFR Befelatanana Pneumology, Antananarivo, Madagascar].

Authors:  Kiady Ravahatra; Michel Tiaray Harison; Oninala Fenitra Rakotondrasoa; Emeline Lucie Ramirana; Iantsotiana Davidson Rakotondrabe; Marie Odette Rasoafaranirina; Anjara Mihaja Nandimbiniaina; Jocelyn Robert Rakotomizao; Joelson Lovaniaina Rakotoson; Rondro Nirina Raharimanana
Journal:  Pan Afr Med J       Date:  2019-07-29

8.  FASE-CPHG study: a panoramic snapshot of difficult-to-treat, severe asthma in French nonacademic hospitals.

Authors:  Laurent Portel; Eric Parrat; Cécilia Nocent-Ejnaini; Gilles Mangiapan; Anne Prud'homme; Jean-Philippe Oster; Corinne Aperre de Vecchi; Cyril Maurer; Chantal Raherison; Didier Debieuvre
Journal:  ERJ Open Res       Date:  2019-10-30

9.  Cost comparison of second-line treatment options for late stage non-small-cell lung cancer: cost analysis for Italy.

Authors:  Bjoern Schwander; Simona Ravera; Giovanni Giuliani; Mark Nuijten; Stefan Walzer
Journal:  Clinicoecon Outcomes Res       Date:  2012-09-03

10.  [Clinical aspects of primary lung cancers in the cancer ward of CHUA-HUJRA Antananarivo].

Authors:  Valéry Refeno; Nomeharisoa Rodrigue Emile Hasiniatsy; Ny Ony Tiana Florence Andrianandrasana; Andriatsihoarana Voahary Nasandratriniavo Ramahandrisoa; Jean Marc Rakotonarivo; Joée Larissa Maevazaka; Hanitrala Jean Louis Rakotovao; Florine Rafaramino
Journal:  Pan Afr Med J       Date:  2015-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.